IR@PKUHSC  > 北京大学临床肿瘤学院  > 胃肠肿瘤中心
学科主题临床医学
A Randomized, Multicenter, Open-label, Phase III Study to Compare the Efficacy and Safety of Capecitabine Plus Paclitaxel Followed by Capecitabine Maintenance (PX-X) With Capecitabine Plus Cisplatin (XP) as a First-line Chemotherapy for Recurrent or Metastatic Gastric Cancer (PAC-C Study)
Zhang, X.1; Shen, L.1; Lu, Z.1; Hu, B.2; Fan, Q.3; Li, W.4; Liu, W.5; Liu, T.6; Pan, Y.7; Xu, N.8
刊名EUROPEAN JOURNAL OF CANCER
2011-09-01
suppl.1页:S471-S472
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000295752801637
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/64788
专题北京大学临床肿瘤学院_胃肠肿瘤中心
作者单位1.Peking Univ, Canc Hosp, Dept GI Oncol, Beijing 100871, Peoples R China
2.Anhui Prov Hosp, Dept Oncol, Hefei, Peoples R China
3.Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China
4.Jilin Univ, Hosp 1, Dept Oncol, Changchun 130023, Peoples R China
5.Hebei Tumour Hosp, Dept Med Oncol, Changchun, Peoples R China
6.Zhongshan Hosp, Dept Med Oncol, Shanghai, Peoples R China
7.Anhui Med Univ, Affiliated Hosp 1, Dept Med Oncol, Hefei, Peoples R China
8.Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, Hefei, Peoples R China
推荐引用方式
GB/T 7714
Zhang, X.,Shen, L.,Lu, Z.,et al. A Randomized, Multicenter, Open-label, Phase III Study to Compare the Efficacy and Safety of Capecitabine Plus Paclitaxel Followed by Capecitabine Maintenance (PX-X) With Capecitabine Plus Cisplatin (XP) as a First-line Chemotherapy for Recurrent or Metastatic Gastric Cancer (PAC-C Study)[J]. EUROPEAN JOURNAL OF CANCER,2011,suppl.1:S471-S472.
APA Zhang, X..,Shen, L..,Lu, Z..,Hu, B..,Fan, Q..,...&Xu, N..(2011).A Randomized, Multicenter, Open-label, Phase III Study to Compare the Efficacy and Safety of Capecitabine Plus Paclitaxel Followed by Capecitabine Maintenance (PX-X) With Capecitabine Plus Cisplatin (XP) as a First-line Chemotherapy for Recurrent or Metastatic Gastric Cancer (PAC-C Study).EUROPEAN JOURNAL OF CANCER,suppl.1,S471-S472.
MLA Zhang, X.,et al."A Randomized, Multicenter, Open-label, Phase III Study to Compare the Efficacy and Safety of Capecitabine Plus Paclitaxel Followed by Capecitabine Maintenance (PX-X) With Capecitabine Plus Cisplatin (XP) as a First-line Chemotherapy for Recurrent or Metastatic Gastric Cancer (PAC-C Study)".EUROPEAN JOURNAL OF CANCER suppl.1(2011):S471-S472.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, X.]的文章
[Shen, L.]的文章
[Lu, Z.]的文章
百度学术
百度学术中相似的文章
[Zhang, X.]的文章
[Shen, L.]的文章
[Lu, Z.]的文章
必应学术
必应学术中相似的文章
[Zhang, X.]的文章
[Shen, L.]的文章
[Lu, Z.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。